Natsuko Inoue

575 total citations
16 papers, 450 citations indexed

About

Natsuko Inoue is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Natsuko Inoue has authored 16 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Natsuko Inoue's work include Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (4 papers). Natsuko Inoue is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (4 papers). Natsuko Inoue collaborates with scholars based in Japan and United States. Natsuko Inoue's co-authors include Yasuo Miyoshi, Kazumasa Naruhashi, Akira Tsuji, Hiromi Muraoka, Nagao Suzuki, Yoshimichi Sai, Ikumi Tamai, Juro Takahashi, Akimitsu Tsutou and Kayo Osawa and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Natsuko Inoue

16 papers receiving 441 citations

Peers

Natsuko Inoue

ONCOL

PPCH

PFM

Lyn M. Huff United States

M. Eileen Dolan United States

Bibo Yuan China

Alessandro Barbarulo United Kingdom

Rie Shibuya Japan

Shunji Kamazawa Japan

Shaolin Ma China

Alice Melão Portugal

Julie Turzanski United Kingdom

Yu Dai China

Lyn M. Huff United States

Natsuko Inoue

305 ×1.3

366 ×1.6

ONCOL

106 ×1.2

90 ×1.2

PPCH

19 ×0.3

PFM

Citations per year, relative to Natsuko Inoue Natsuko Inoue (= 1×) peers Lyn M. Huff

Countries citing papers authored by Natsuko Inoue

Since Specialization

Citations

This map shows the geographic impact of Natsuko Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natsuko Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natsuko Inoue more than expected).

Fields of papers citing papers by Natsuko Inoue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natsuko Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natsuko Inoue. The network helps show where Natsuko Inoue may publish in the future.

Co-authorship network of co-authors of Natsuko Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Natsuko Inoue. A scholar is included among the top collaborators of Natsuko Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natsuko Inoue. Natsuko Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jin, Denan, Shinji Takai, Natsuko Inoue, et al.. (2024). IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through Notch signaling. Journal of Leukocyte Biology. 117(1). 1 indexed citations

Fujimoto, Yukie, Takahiro Watanabe, Natsuko Inoue, et al.. (2020). Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes. Anticancer Research. 40(4). 2141–2150. 14 indexed citations

Inoue, Natsuko, Wen Li, Yukie Fujimoto, et al.. (2019). High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer. Anticancer Research. 39(9). 5009–5018. 17 indexed citations

Fujimoto, Yukie, Natsuko Inoue, Koji Morimoto, et al.. (2019). Significant association between high serum CCL5 levels and better disease‐free survival of patients with early breast cancer. Cancer Science. 111(1). 209–218. 24 indexed citations

Johmura, Yoshikazu, Ichiro Maeda, Narumi Suzuki, et al.. (2018). Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer. Journal of Clinical Investigation. 128(12). 5603–5619. 42 indexed citations

Watanabe, Takahiro, Akira I. Hida, Natsuko Inoue, et al.. (2017). Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers. Breast Cancer Research and Treatment. 168(1). 135–145. 29 indexed citations

Nishimukai, Arisa, Natsuko Inoue, Masashi Takeda, et al.. (2017). Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers. PLoS ONE. 12(9). e0184508–e0184508. 6 indexed citations

Yagi, Tomoko, Natsuko Inoue, Ayako Yanai, et al.. (2014). Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers. Breast Cancer. 23(2). 224–230. 10 indexed citations

Yanai, Ayako, Natsuko Inoue, Tomoko Yagi, et al.. (2014). Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer. Clinical Breast Cancer. 15(3). 197–203. 18 indexed citations

10.

Miyake, Tomohiro, Takashi Ito, Ayako Yanai, et al.. (2013). C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis. Breast Cancer. 22(4). 366–373. 6 indexed citations

11.

Murase, Keiko, Ayako Yanai, Masaru Saito, et al.. (2012). Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers. Breast Cancer. 21(1). 52–57. 11 indexed citations

12.

Osawa, Kayo, Kazuya Uchino, Natsuko Inoue, et al.. (2010). APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese.. PubMed. 11(5). 1181–6. 25 indexed citations

13.

Osawa, Kayo, Natsuko Inoue, Kana Yoshida, et al.. (2009). MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. Journal of Experimental & Clinical Cancer Research. 28(1). 10–10. 58 indexed citations

14.

Osawa, Kayo, Kana Yoshida, Natsuko Inoue, et al.. (2008). Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. Journal of Experimental & Clinical Cancer Research. 27(1). 49–49. 82 indexed citations

15.

Naruhashi, Kazumasa, Ikumi Tamai, Natsuko Inoue, et al.. (2002). Involvement of Multidrug Resistance-Associated Protein 2 in Intestinal Secretion of Grepafloxacin in Rats. Antimicrobial Agents and Chemotherapy. 46(2). 344–349. 62 indexed citations

16.

Naruhashi, Kazumasa, Ikumi Tamai, Natsuko Inoue, et al.. (2001). Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein. Journal of Pharmacy and Pharmacology. 53(5). 699–709. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact